Globus MedicalGMED +5.15%97 Pretax Margin % is 20.67% as of Mar. 2026, which is 7% below its 10-year median of 22.18. GuruFocus rates GMED with a GF Score™ of 97/100 and a GF Value™ of $98.67 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Globus Medical ranks better than 87.39% on this metric.
The historical rank and industry rank for Globus Medical's Pretax Margin % or its related term are showing as below:
GMED'
s Pretax Margin % Range Over the Past 10 Years
Min: 4.79 Med: 22.18 Max: 27.89
Current: 21.24
GMED's Pretax Margin % is ranked better than 87.39% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs GMED: 21.24
Globus Medical (NYSE:GMED) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Globus Medical Pretax Margin % Related Terms
Globus Medical Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Globus Medical's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GMED vs PEN, PODD, BRKR: Pretax Margin % Comparison
For the Medical Devices subindustry, Globus Medical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Globus Medical's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical (GMED) has a Pretax Margin % of 20.67% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Globus Medical and its competitors. This is near median its historical median of 22.18. Over the past decade, Globus Medical's Pretax Margin % has ranged from 4.79 to 27.89. According to the industry distribution chart, Globus Medical ranks #103 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 12.6%.
Is Globus Medical's Pretax Margin % too high?
Globus Medical's current Pretax Margin % of 20.67% is near median its 10-year median of 22.18. Over the past 10 years, this metric has ranged from a low of 4.79 to a high of 27.89. The Medical Devices & Instruments industry median Pretax Margin % is 2.40. Globus Medical's value of 20.67% is 761.3% above this industry median. Based on the distribution chart, Globus Medical ranks #103 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Pretax Margin % compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #103 out of 817 companies for Pretax Margin %. This places Globus Medical in the top 13% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.40. Globus Medical's value of 20.67% is 761.3% above this benchmark. Historically, Globus Medical's own Pretax Margin % has ranged from 4.79 to 27.89 over the past decade. While the company's 10-year median is 22.18 vs. the industry median of 2.40, Globus Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current Pretax Margin % of 20.67% is 761.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Globus Medical and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current Pretax Margin % is 20.67%, which is near median its own 10-year median of 22.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.67, compared to a current price of $79.87 — trading 19.1% below its estimated fair value. The current Pretax Margin % is 20.67%, which is near median its 10-year median of 22.18 and 761.3% above the Medical Devices & Instruments industry median of 2.40. Globus Medical's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Globus Medical (GMED), the current Pretax Margin % is 20.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of $79.87 is trading 19.1% below its estimated GF Value™ of $98.67.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for GMED:
Pretax Margin %: 20.67% (near median its 10-year median of 22.18)
GF Value™: $98.67 vs. price of $79.87 (19.1% below fair value)
Industry Position: 761.3% above the Medical Devices & Instruments median (#103 of 817)
No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
97GF Score
Get the complete analysis for GMED
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GMED has been successfully added to your 
